Gilead Sciences: Rating Upgrade Warranted On HIV Division Strength

Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...
Technology Networks

From Platform Engineering to Next-Generation Therapies: The ReiThera Story

In this article, ReiThera's scientific and operational leaders discuss ReiThera’s proprietary platforms, process development ...

Merck's oral HIV treatment non-inferior to Gilead's Biktarvy in late-stage trial

Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...
The Christian Science Monitor

In ‘The Name on the Wall,’ Hervé Le Tellier charts rise of extremism

The Name on the Wall” unspools the short life of a French resistance foot soldier, whose ordinary bravery contrasted with the ...
IPPMEDIA

Xi Focus: Leading China's drive to enhance law-based governance

The law on publicity and education on the rule of law, which highlights lifelong legal education for citizens, is designed to consolidate the social foundation for comprehensively advancing law-based ...
Saffarazzi

Stiglitz’s G20 Warning: Can SA Close the Wealth Gap?

On November 4, Nobel laureate Joseph Stiglitz handed President Cyril Ramaphosa the world’s first G20 Inequality Report, ...
BMJ

Enhancing healthcare providers’ advance care planning competence with large language models: protocol for the development of an AI chatbot and its evaluation in a randomised ...

Introduction Advance care planning (ACP) can support individuals to express their autonomy in the decision-making process for future care. Traditional ACP training for healthcare providers faces ...